tiprankstipranks
Advertisement
Advertisement
LB Pharmaceuticals: Buy Rating Reiterated, $45 Price Target Maintained on LB-102 Late-Stage Pipeline and Multi-Billion-Dollar Sales Potential
PremiumRatingsLB Pharmaceuticals: Buy Rating Reiterated, $45 Price Target Maintained on LB-102 Late-Stage Pipeline and Multi-Billion-Dollar Sales Potential
21d ago
LB Pharmaceuticals price target raised to $37 from $31 at Roth Capital
Premium
The Fly
LB Pharmaceuticals price target raised to $37 from $31 at Roth Capital
29d ago
LB Pharmaceuticals reports Q1 EPS (67c), consensus (67c)
Premium
The Fly
LB Pharmaceuticals reports Q1 EPS (67c), consensus (67c)
1M ago
LB Pharmaceuticals files to sell 4.78M shares of common stock for holders
PremiumThe FlyLB Pharmaceuticals files to sell 4.78M shares of common stock for holders
2M ago
LB Pharmaceuticals price target raised to $40 from $35 at Stifel
Premium
The Fly
LB Pharmaceuticals price target raised to $40 from $35 at Stifel
3M ago
LB Pharmaceuticals reports Q4 EPS (45c), consensus (32c)
Premium
The Fly
LB Pharmaceuticals reports Q4 EPS (45c), consensus (32c)
3M ago
LB Pharmaceuticals management to meet with Piper Sandler
PremiumThe FlyLB Pharmaceuticals management to meet with Piper Sandler
4M ago
LB Pharmaceuticals Announces $100 Million Private Placement Financing
Premium
Company Announcements
LB Pharmaceuticals Announces $100 Million Private Placement Financing
4M ago
LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement
Premium
The Fly
LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100